Agenda 2025
|
|
|
|---|---|
| 8:00 am | REGISTRATION AND BREAKFAST |
| 8:25 am | Erle Robertson Ph.D., Vice Chair of Otorhinolaryngology–Head and Neck Surgery, Professor of Microbiology Perelman School of Medicine, University of Pennsylvania, PA. ♦ Opening Remarks |
| First Session | Moderator: Dr. Yanming Du, Ph.D., Professor, Baruch S. Blumberg Institute, Doylestown, PA. |
| 8:30 – 9:00 am | Dr. Harvey Freedman, M.D., Professor of Medicine, University of Pennsylvania, Philadelphia, PA. ♦ “Current status of the HSV-2 gC2/gD2/gE2 trivalent mRNA-LNP vaccine for genital herpes”. |
| 9:00 – 9:20 am | Dr. Sumita Bhaduri-McIntosh, M.D., Ph.D., Professor, Dept. of Pediatrics, University of Florida, FL. ♦ “Warning! Two danger sensing pathways reactivate EBV in DLBCL-derived lines”. |
| 9:20 – 9:40 am | Dr. Christoph Weigel, Ph.D., Postdoctoral fellow, Dr. Robert Baiocchi Lab, The Ohio State University, Columbus, OH. ♦ “EBV DNA methylation profiling in lymphoma reveals diagnostic applications”. |
| 9:40 – 10:00 am | Ms. Rachel Sklutuis, Ph.D., candidate, Dr Italo tempera Lab, The Wistar Institute, Philadelphia, PA. ♦ “Epstein-Barr Virus Exploits Host NAD⁺ Metabolism to Reprogram Chromatin and Drive B Cell Transformation”. |
| 10:00 – 10:20 am | COFFEE BREAK |
| Second session | Moderator: Dr. Laurie T. Krug, Ph.D., Stadtman Investigator, NCI CCR HAMB, National Institutes of Health, Bethesda, MD. |
| 10:20 – 11:20 am | Dr. Jae U. Jung, Ph.D., The Betsy DeWindt Chair, Associate Chief of Emerging Science & Technology, Chair of Infection Biology Department, Director of Global Center for Pathogen and Human Health Research, Director of Experimental Therapeutics Program, Cleveland Clinic, Cleveland, OH. ♦ Gertrude and Werner Henle Lectureship Keynote Speaker ♦ “Gamma herpesvirus-induced metabolic reprograming for viral malignancy”. |
| 11:20 – 11:40 am | Dr. Greg Glenn, M.D. CEO, Pinion Immunotherapeutics, Rockville, MD. ♦ “Development of a Therapeutic mRNA Vaccine for HSV Genital Herpes”. |
| 11:40 – 12:00 pm | Dr. Yan Yuan, Ph.D., Professor, Shandong University, China. ♦ "KSHV Infection of Mesenchymal Stem Cells Leads to Osteosarcoma". |
| 12:00 – 1:20 pm | LUNCH |
| Third session | Moderator: Dr. Sita Awasthi, Ph.D., Associate Professor Research, University of Pennsylvania, PA. |
| 1:20 – 1:50 pm | Dr. Stephen Schuster M.D., Professor of Medicine, University of Pennsylvania, PA. ♦ “Human Herpesvirus-related Lymphomas: Biology and Current Management”. |
| 1:50 – 2:10 pm | Dr. Michael McIntosh, Ph.D., Associate Professor, Department of Pediatrics, University of Florida, FL. ♦ “Turning Off the Latent-to-Lytic Switch of Epstein-Barr Virus”. |
| 2:10 – 2:30 pm | Ashwin Nair, Ph.D., Visiting Post-Doctoral fellow, Robert Yarchoan Lab, National Cancer Institute, Bethesda, MD. ♦ “ORF75 SUMOylation and SUMO-Interacting Motifs Are Essential for Its Stability and Function during KSHV Pathogenesis”. |
| 2:30 – 2:50 pm | Mr. Matthew Tyl, Ph.D. Candidate, Dr. Ileana Cristea lab, Princeton University, Princeton, NJ. ♦ “Infection-induced lysine lactylation enables herpesvirus immune evasion”. |
| 2:50 – 3:10 pm | Ms. Jenna Nosek, Graduate Student, Dr. Neal DeLuca Lab, University of Pittsburgh, Pittsburgh, PA. ♦ “Accessibility of the HSV-1 genome throughout productive infection". |
| 3:10 – 3:30 pm | AFTERNOON BREAK |
| Final Session | Moderator: Dr. Italo Tempera, Ph.D., Associate Professor, Wistar Institute, Philadelphia, PA. |
| 3:30 – 4:00 pm | Dr. Ahmed Diab, Ph.D., Assistant Professor, University of Pennsylvania, Philadelphia, PA. ♦ “Intra-tumor heterogeneity in HPV oncogene expression as a determinant of oropharyngeal cancer progression and therapy response”. |
| 4:00 – 4:20 pm | Dr. Anna Grosskopf, Ph.D., Postdoctoral Visiting Fellow, Dr. Laurie Krug Lab, HIV & AIDS Malignancy Branch NCI, Bethesda, MD ♦ ”Eph receptor tyrosine kinases are functional entry receptors for the murine gammaherpesvirus 68”. |
| 4:20 – 4:40 pm | Ms. Leena Yoon, Ph.D. Candidate, Dr Paul Lieberman Lab, Wistar Institute, Philadelphia, PA. ♦ “Dynamic Immune Responses to EBV in Primary Infection and Implications for MS”. |
| 4:40 – 5:00 pm | Dr. Mark Painter, Postdoctoral Fellow, E. John Wherry lab, University of Pennsylvania, PA. ♦ “Leveraging T cells as antigen biosensors to interrogate herpesvirus reactivation”. |
| 5:00 pm | RECEPTION |
